TotalMarketCap

Alumis

ALMSNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$756.549 M

$5.85 -10.76%

Close of 6 Nov 2026

As of 6 Nov 2026, Alumis (ALMS) has a market capitalization of $756.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$24.1M

#2918 by revenue

Earnings

-$243.3M

Loss-making

Shares outstanding

126,377,692

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #159Collegium PharmaceuticalCOLL$816.5M
  2. #160CryoportCYRX$813.4M
  3. #161AlumisALMS$756.5M
  4. #162AnnexonANNX$755.5M
  5. #163ArdelyxARDX$750.3M

What if Alumis were worth as much as…

Open the what-if tool →

Gold $28.2T

$218,154.45

Per share 37,323× higher

Bitcoin $1.53T

$11,803.96

Per share 2,019× higher

Apple $5.02T

$38,751.29

Per share 6,630× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Alumis are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.